Loading...
•
Dec 31, 2024
Quest Diagnostics Q4 2024 Earnings Report
Reported impressive revenue growth and improved profitability.
Key Takeaways
Quest Diagnostics reported a strong Q4 2024, with a 14.5% increase in revenue to $2.62 billion and a 14.7% increase in reported EPS to $1.95. The company's full-year revenue grew by 6.7% to $9.87 billion, and it provided guidance for full-year 2025 with EPS expected to be between $8.34 and $8.59.
Fourth quarter revenues increased by 14.5% to $2.62 billion compared to 2023.
Reported diluted EPS for the fourth quarter was $1.95, a 14.7% increase from 2023.
Full year revenues grew by 6.7% to $9.87 billion compared to 2023.
The board of directors has authorized a 6.7% increase in the quarterly dividend to $0.80 per share.
Quest Diagnostics
Quest Diagnostics
Forward Guidance
The company estimates its full year 2025 net revenues to be between $10.70 billion and $10.85 billion, reported diluted EPS to be between $8.34 and $8.59, adjusted diluted EPS to be between $9.55 and $9.80, and cash provided by operations to be approximately $1.45 billion.
Positive Outlook
- Net revenues are expected to increase between 8.4% and 9.9%.
- Reported diluted EPS is projected to be between $8.34 and $8.59.
- Adjusted diluted EPS is anticipated to be between $9.55 and $9.80.
- Cash provided by operations is estimated to be approximately $1.45 billion.
- Capital expenditures are projected to be approximately $500 million.